Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities:    
Net income $ 16,756 $ 34,160
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 66,744 65,535
Amortization 23,749 25,449
Amortization of deferred financing costs and original issue discount 2,427 2,872
Foreign currency exchange loss 2,483 923
Pension and postretirement healthcare benefit expense (3) 2,185
Pension and postretirement healthcare benefit funding (4,153) (3,632)
Deferred income tax provision 5,990 10,844
Net (gain) loss on asset disposals 8,401 (8,839)
Stock compensation 12,286 8,770
Equity in net income from affiliated companies (19,842) (14,364)
Dividends received from affiliated companies 15,098 5,072
Net interest income on swaps designated as net investment hedges (2,197) (4,478)
Other, net (1,225) (4,356)
Working capital changes that provided (used) cash, excluding the effect of acquisitions and dispositions:    
Receivables (24,601) (46,261)
Inventories (9,276) (12,191)
Prepaids and other current assets 42 2,183
Accounts payable (15,322) (189)
Accrued liabilities (15,248) (3,691)
Net cash provided by operating activities 62,109 59,992
Cash flows from investing activities:    
Purchases of property, plant and equipment (50,510) (65,475)
Proceeds from sale of product line 0 26,665
Proceeds from sale of assets 10,330 0
Proceeds from sale of investment (1,761) 0
Net interest proceeds on swaps designated as net investment hedges 2,197 4,478
Other, net 0 475
Net cash used in investing activities (36,222) (33,857)
Cash flows from financing activities:    
Draw down of revolving credit facilities 164,704 74,863
Repayments of revolving credit facilities (163,928) (72,247)
Debt issuance costs (3,023) 0
Repayments of long-term debt 0 (5,000)
Stock repurchases (3,889) (1,339)
Proceeds from stock options exercised 181 3,475
Other, net 0 (153)
Net cash used in financing activities (5,955) (401)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (3,261) (1,501)
Net change in cash, cash equivalents and restricted cash 16,671 24,233
Cash, cash equivalents and restricted cash at beginning of period 73,917 59,726
Cash, cash equivalents and restricted cash at end of period $ 90,588 $ 83,959